| Total cohort (n = 246) | Event group (n = 26) | No event group (n = 220) | P-value |
---|---|---|---|---|
Mean ± SD / Median (IQR) / n (%) | Mean ± SD / Median (IQR) / n (%) | Mean ± SD / Median (IQR) / n (%) |  | |
Age (years) | 68.7 ± 9.2 | 71.5 ± 7.9 | 68.3 ± 9.3 | 0.093 |
Male gender | 141 (57.3) | 17 (65.4) | 124 (56.4) | 0.379 |
Newly diagnosed PAD patient upon inclusion | 17 (6.9) | 2 (7.7) | 15 (6.8) | 0.868 |
Chronic PAD patient upon inclusion | 229 (93.1) | 24 (92.3) | 205 (93.2) | 0.868 |
Time between diagnosis and inclusion (months) | 33 (8–101) | 81 (19–121) | 26 (7–89) | 0.028* |
Intermittent claudication | 207 (84.1) | 22 (84.6) | 185 (84.1) | 0.945 |
Chronic limb ischemia | 39 (15.9) | 4 (15.4) | 35 (15.9) | 0.945 |
History of myocardial infarction | 72 (29.3) | 14 (53.8) | 58 (26.8) | 0.004* |
History of stroke | 37 (15) | 10 (38.5) | 27 (12.3) | 0.001* |
Current smoking | 94 (38.2) | 11 (42.3) | 83 (37.7) | 0.649 |
Pack years | 29 (15–40) | 33 (18–50) | 29 (15–40) | 0.175 |
BMI (kg/m2) | 26.4 ± 4.41 | 27.4 ± 5.9 | 26.3 ± 4.2 | 0.390 |
DM2 | 67 (27.2) | 10 (38.5) | 57 (25.9) | 0.174 |
HbA1c (mmol/mol) | 43 (37–51) | 43 (37–53) | 43 (37–50) | 0.752 |
Creatinine (μmol/L) | 85 (72–104) | 101 (77–145) | 83 (71–101) | 0.006* |
eGFR (ml/min/1.73 m2) | 71 (58–83) | 59 (42–80) | 72 (59–84) | 0.022* |
Haemoglobin (mmol/L) | 8.66 ± 0.97 | 8.3 ± 1.1 | 8.7 ± 0.95 | 0.026* |
Haematocrit (L/L) | 0.42 ± 0.04 | 0.4 ± 0.04 | 0.42 ± 0.04 | 0.027* |
Thrombocytes (×  103 /mm3) | 272 ± 87 | 277 ± 82 | 271 ± 88 | 0.714 |
Leukocytes (×  109/L) | 7.89 ± 2.2 | 8.44 ± 3.1 | 7.83 ± 2 | 0.342 |
Neutrophils (%) | 62.2 ± 8.2 | 64 ± 7.5 | 62 ± 8.2 | 0.228 |
Lymphocytes (%) | 25.8 ± 6.8 | 24.1 ± 6.5 | 26 ± 6.9 | 0.168 |
Eosinophils (%) | 2 (1–3) | 2 (2–3) | 2 (1–3) | 0.254 |
Basophils (%) | 1 (1–1) | 1 (1–1) | 1 (1–1) | 0.544 |
Monocytes (%) | 8.83 ± 2.4 | 8.8 ± 3.2 | 8.8 ± 2.3 | 0.901 |
NLR | 2.4 (1.9–3.1) | 2.5 (2–3.4) | 2.4 (1.9–3.1) | 0.288 |
ABI at diagnosis | Â | Â | Â | 0.156 |
> 1.30 (incompressible) | 17 (6.9) | 0 (0) | 17 (7.7) |  |
0.91–1.30 | 0 (0) | 0 (0) | 0 (0) |  |
0.70–0.90 | 109 (44.3) | 9 (34.6) | 100 (45.5) |  |
0.40–0.69 | 99 (40.2) | 16 (61.5) | 83 (37.7) |  |
< 0.40 | 21 (8.5) | 1 (3.8) | 20 (9.1) |  |